Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

Primary: - To characterize the physiologic changes of the autonomic nervous system, demonstrated by heart rate variability (HRV) high frequency (HF) spectral analysis, before and after a 15 minute, one-time, guided relaxation program for cancer patients. Secondary: - To assess whether change of HRV correlates with subjective feeling for anxiety, based on visual analog scale scores.


Study summary:

Rhythm changes in your heart rate are part of the "autonomic" nervous system. This is the part of your nervous system that controls the body functions that you do not have to think about. Researchers want to find out if a "guided relaxation" session will make your heart rate more variable, with more rhythm changes. If you are found to be eligible to take part in this study, you will first answer a brief questionnaire that will measure several symptoms, such as pain and anxiety (worry). This questionnaire will take less than 5 minutes. You will also be asked questions about your alcohol and smoking history, and if you have ever used relaxation or meditation techniques in the past. This will also take less than 5 minutes. You will then be asked to lay on your back, on a hospital bed or exam table. Electrodes will be placed along your chest, the same way they are placed for an electrocardiogram (ECG--a test to measure the electrical activity of the heart). You will be asked to rest for 15 minutes, and then your heart rhythm will be recorded for 5 minutes. After this first recording, you will begin the relaxation program by listening to an audio recording for about 15 minutes, using headphones. After the relaxation program has ended, your heart rhythm will be recorded for another 5-minute period while you are resting. You will then be asked to complete the same questionnaire as before. The entire procedure will take about 45-60 minutes. After this second questionnaire, your participation on this study will be over. This is an investigational study. Up to 20 people will take part in this study. All will be enrolled at M. D. Anderson.


Criteria:

Inclusion Criteria: 1. Written informed consent 2. Normal cognition (per treating physician's assessment) Exclusion Criteria: 1. Dementia 2. Psychosis 3. Delirium 4. Not fluent in English 5. Cardiac dysrhythmia 6. Inability to lay supine 7. Pacemaker


NCT ID:

NCT00735618


Primary Contact:

Principal Investigator
Ying Guo, MD
U.T. M.D. Anderson Cancer Center Professor


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.